IDO1 and cancer: This indicates that IDO expression may be correlated with EBV-associated cancers presenting latency II and/or III, since PL is the only cancer of the above-mentioned ones that presents latency I. A summary of the detection of IDO expression in EBV-associated malignancies is in Table 2.